These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21884817)

  • 21. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL; Ueki K; Jhung SL; Koh J; Louis DN
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
    Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
    Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
    Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Pellin A; Lopez-Guerrero JA; Callaghan R; Benito R; Roldan P; Piquer J; Llacer J; Barbera J
    Clin Neuropathol; 2005; 24(5):209-18. PubMed ID: 16167544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
    Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years.
    Korshunov A; Sycheva R; Golanov A
    Cancer; 2005 Aug; 104(4):825-32. PubMed ID: 15981281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ploidy status and copy number aberrations in primary glioblastomas defined by integrated analysis of allelic ratios, signal ratios and loss of heterozygosity using 500K SNP Mapping Arrays.
    Gardina PJ; Lo KC; Lee W; Cowell JK; Turpaz Y
    BMC Genomics; 2008 Oct; 9():489. PubMed ID: 18928532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
    Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
    J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.
    Wemmert S; Ketter R; Rahnenführer J; Beerenwinkel N; Strowitzki M; Feiden W; Hartmann C; Lengauer T; Stockhammer F; Zang KD; Meese E; Steudel WI; von Deimling A; Urbschat S
    Neoplasia; 2005 Oct; 7(10):883-93. PubMed ID: 16242071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
    Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
    Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
    Suwala AK; Stichel D; Schrimpf D; Maas SLN; Sill M; Dohmen H; Banan R; Reinhardt A; Sievers P; Hinz F; Blattner-Johnson M; Hartmann C; Schweizer L; Boldt HB; Kristensen BW; Schittenhelm J; Wood MD; Chotard G; Bjergvig R; Das A; Tabori U; Hasselblatt M; Korshunov A; Abdullaev Z; Quezado M; Aldape K; Harter PN; Snuderl M; Hench J; Frank S; Acker T; Brandner S; Winkler F; Wesseling P; Pfister SM; Reuss DE; Wick W; von Deimling A; Jones DTW; Sahm F
    Acta Neuropathol; 2021 Jul; 142(1):179-189. PubMed ID: 33876327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients.
    Kakkar A; Suri V; Jha P; Srivastava A; Sharma V; Pathak P; Sharma MC; Sharma MS; Kale SS; Chosdol K; Phalak M; Sarkar C
    Neurol India; 2011; 59(2):254-61. PubMed ID: 21483128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.
    Idbaih A; Marie Y; Lucchesi C; Pierron G; Manié E; Raynal V; Mosseri V; Hoang-Xuan K; Kujas M; Brito I; Mokhtari K; Sanson M; Barillot E; Aurias A; Delattre JY; Delattre O
    Int J Cancer; 2008 Apr; 122(8):1778-86. PubMed ID: 18076069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
    Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
    J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology of glioblastoma: Classification and mutational locations.
    Soomro SH; Ting LR; Qing YY; Ren M
    J Pak Med Assoc; 2017 Sep; 67(9):1410-1414. PubMed ID: 28924284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas.
    Saigusa K; Hashimoto N; Tsuda H; Yokoi S; Maruno M; Yoshimine T; Aoyagi M; Ohno K; Imoto I; Inazawa J
    Cancer Sci; 2005 Oct; 96(10):676-83. PubMed ID: 16232199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of human glioblastomas using a genomic microarray system.
    Suzuki T; Maruno M; Wada K; Kagawa N; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2004; 21(1):27-34. PubMed ID: 15696966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioblastomas in the older old.
    Kleinschmidt-DeMasters BK; Lillehei KO; Varella-Garcia M
    Arch Pathol Lab Med; 2005 May; 129(5):624-31. PubMed ID: 15859633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.
    Sung T; Miller DC; Hayes RL; Alonso M; Yee H; Newcomb EW
    Brain Pathol; 2000 Apr; 10(2):249-59. PubMed ID: 10764044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.